NCT01949571View on ClinicalTrials.gov

Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

September 30, 2012

Conditions
Drug-withdrawal.Drug AbuseDrug-induced Depressive StateAOD CravingAODR Depressive State
Interventions
DRUG

Mirtazapine (REMERON, Schering-Plough-Organon)

During the first and second phase of the study,the mirtazapine group received 30 mg of mirtazapine daily. During the third phase, the mirtazapine group received 15 mg of mirtazapine.

Trial Locations (1)

14370

National Institute of Psychiatry, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente

OTHER

NCT01949571 - Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts. | Biotech Hunter | Biotech Hunter